Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Received May 13, 2011
- Revision received July 14, 2011
- Accepted July 15, 2011
- Published online October 21, 2011.
Copyright & Usage
Copyright © 2011 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved
Author Information
- YOUNG KIM1,
- MATTHIAS SCHMIDT1,
- TOMOYUKI ENDO2,3,
- DESHENG LU2,
- DENNIS CARSON2 and
- INGO G.H. SCHMIDT-WOLF1⇓
- 1Department of Internal Medicine III, Center for Integrated Oncology (CIO), University of Bonn, Bonn, Germany
- 2University of California San Diego (UCSD), Moores Cancer Center, La Jolla, CA, U.S.A.
- 3Department of Internal Medicine II, Hokkaido University Graduate School of Medicine, Sapporo, Hokkaido, Japan
- Correspondence to: Professor Dr. Ingo G.H. Schmidt-Wolf, Department of Internal Medicine III, University Hospital Bonn, Sigmund-Freud-Str. 25, 53105 Bonn, Germany, Tel: +49 22828715507, Fax: +49 22828715849, e-mail: ingo.schmidt-wolf{at}ukb.uni-bonn.de
Cited By...
In this issue
Jump to section
Related Articles
Cited By...
- Targeting Histone Demethylases in MYC-Driven Neuroblastomas with Ciclopirox
- {beta}-Catenin Inhibitor BC2059 Is Efficacious as Monotherapy or in Combination with Proteasome Inhibitor Bortezomib in Multiple Myeloma
- In Vitro Apoptosis Induction by Fenofibrate in Lymphoma and Multiple Myeloma
- Griseofulvin Efficiently Induces Apoptosis in In Vitro Treatment of Lymphoma and Multiple Myeloma
- Targeting Prostate Cancer with a Combination of WNT Inhibitors and a Bi-functional Peptide
- Clofibrate Demonstrates Efficacy in In Vitro Treatment of Lymphoma and Multiple Myeloma
- In Vitro Efficacy of Naftifine Against Lymphoma and Multiple Myeloma
- Flunarizine Exhibits In Vitro Efficacy Against Lymphoma and Multiple Myeloma Cells
- In Vitro Efficacy of Cinnarizine Against Lymphoma and Multiple Myeloma
- Effect of Wnt Inhibitors in Pancreatic Cancer
- Targeting the Wnt/Beta-Catenin Pathway in Renal Cell Carcinoma
- Blocking eIF5A Modification in Cervical Cancer Cells Alters the Expression of Cancer-Related Genes and Suppresses Cell Proliferation
- Targeting the Wnt/Beta-Catenin Pathway in Multiple Myeloma
- Targeting Renal Cancer with a Combination of WNT Inhibitors and a Bi-Functional Peptide
- Antagonistic Effect of Small-molecule Inhibitors of Wnt/{beta}-catenin in Multiple Myeloma